Uncategorized

PerkinElmer Launches Clinical Whole Genome Sequencing Services

PerkinElmer Launches Clinical Whole Genome Sequencing Services Thu Aug, 03 | PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the launch of PerkinElmer Genetics’ clinical genomics services.  Through its integrated laboratories in the U.S., India and China, PerkinElmer offers a global genomic lab testing platform that performs screening

By |2021-05-18T06:33:14-04:00May 18th, 2021|Uncategorized|0 Comments

PerkinElmer and In-Depth Genomics Team Up for Whole Genome Sequencing Diagnostic Program for Rare Diseases

PerkinElmer and In-Depth Genomics Team Up for Whole Genome Sequencing Diagnostic Program for Rare Diseases Sep 14, 2017 COLUMBUS, Ohio September 14, 2017–(BUSINESS WIRE)–National Society of Genetic Counselors Annual Conference, Booth #535 –PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced an innovative collaboration with In-Depth Genomics (IDG) to support IDG’s Whole Genome

By |2021-05-18T06:20:16-04:00May 18th, 2021|Uncategorized|0 Comments

Neuromuscular Disease Foundation (NDF) Launches Whole Genome Sequencing Research for Rare Muscle Disease

Neuromuscular Disease Foundation (NDF) Launches Whole Genome Sequencing Research for Rare Muscle Disease BEVERLY HILLS, CALIF. (PRWEB) DECEMBER 21, 2017 The Neuromuscular Disease Foundation (NDF) – the world’s leading nonprofit organization focused on the rare genetic disease called GNE Myopathy (GNEM, also known as HIBM) is pleased to announce its collaboration with PerkinElmer for

By |2021-06-16T09:39:44-04:00May 18th, 2021|Uncategorized|0 Comments

Parent Project Muscular Dystrophy Selects PerkinElmer to Support Decode Duchenne Program

Parent Project Muscular Dystrophy Selects PerkinElmer to Support Decode Duchenne Program Thu Apr, 05 | WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that Parent Project Muscular Dystrophy (PPMD) has selected the Company to provide genetic testing for its Decode Duchenne program. “We are also grateful to our sponsors, Sarepta Therapeutics

By |2021-05-18T06:09:06-04:00May 18th, 2021|Uncategorized|0 Comments

PerkinElmer Collaborates with Helix to Drive Innovation in Exome-Based Personal Genomics

PerkinElmer Collaborates with Helix to Drive Innovation in Exome-Based Personal Genomics Tue Apr, 10 | WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced a collaboration with Helix, a personal genomics company, to develop and commercialize exome sequencing-based tests that will empower consumers to make proactive health

By |2021-05-18T05:51:15-04:00May 18th, 2021|Uncategorized|0 Comments

PerkinElmer Sponsors the ACMG Foundation’s Day of Caring Event

PerkinElmer Sponsors the ACMG Foundation’s Day of Caring Event Each year, the ACMG Foundation for Genetic and Genomic Medicine with the support of our dedicated corporate partners and medical genetics and genomics professionals from across the country, host the ACMGF Day of Caring event during ACMG’s Annual Meeting. The Day of Caring partner with local non-profit

By |2021-05-18T05:39:52-04:00May 18th, 2021|Uncategorized|0 Comments

PerkinElmer Genomics Opens New State-Of-The-Art Laboratory

PerkinElmer Genomics Opens New State-Of-The-Art Laboratory PerkinElmer Genomics is very proud to announce the opening of our new state-of-the-art laboratory in Pittsburgh, PA.  The new 21,000 square foot expansion and upgrade provides us with the latest in screening and diagnostic technologies.  The expansion also provides us with an increase in capacity, which will allow us

By |2021-05-18T05:33:45-04:00May 18th, 2021|Uncategorized|0 Comments

Enzyvant Announces Collaboration with PerkinElmer to Enable Diagnostic Testing for Farber Disease

Enzyvant Announces Collaboration with PerkinElmer to Enable Diagnostic Testing for Farber Disease Thu Jul, 19 |BASEL, Switzerland and WALTHAM, Mass., July 19, 2018 /PRNewswire/ — Enzyvant, a biopharmaceutical company focused on developing innovative treatments for people living with rare diseases, today announced that it has formed a collaboration with PerkinElmer Genomics, a global genomic testing company.PerkinElmer

By |2021-05-18T05:18:40-04:00May 18th, 2021|Uncategorized|0 Comments

The Lantern Project from Sanofi Genzyme and PerkinElmer Expands Access to Free Diagnostic Genetic Testing for a Number of Lysosomal Storage Disorders

The Lantern Project from Sanofi Genzyme and PerkinElmer Expands Access to Free Diagnostic Genetic Testing for a Number of Lysosomal Storage Disorders Thu Jul, 25 | CAMBRIDGE, Mass., Oct. 15, 2018 /PRNewswire/ — Patients with rare genetic diseases can face a difficult path to a proper diagnosis. Because there is a lower awareness of

By |2021-05-18T04:58:15-04:00May 18th, 2021|Uncategorized|0 Comments

PerkinElmer Genomics Indroduces Physician-Ordered Genetic Screening Test for Proactive Health Management

PerkinElmer Genomics Indroduces Physician-Ordered Genetic Screening Test for Proactive Health Managementt Wed Apr, 03 | WALTHAM, Mass.--(BUSINESS WIRE)--Today, in collaboration with Helix, PerkinElmer, Inc., a global leader committed to innovating for a healthier world, launched GenePrism: Actionable Insights, a new genetic screening test, offering the most comprehensive clinical-grade DNA sequencing and interpretation on the market right now,

By |2021-05-18T04:35:55-04:00May 18th, 2021|Uncategorized|0 Comments
Go to Top